Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy, safety and pharmacokinetic profiles of a plasma-derived VWF/FVIII concentrate (VONCENTO®) in subjects with haemophilia A (SWIFT-HA study).
Skotnicki A, Lissitchkov TJ, Mamonov V, Buevich E, Kuliczkowski K, Goranov S, Kłoczko J, Klukowska A, Stankovic S, Gercheva L, Chernova T, Hellmann A, Dmoszyńska A, Zawilska K, Veldman A, Joch C, Seifert W. Skotnicki A, et al. Among authors: seifert w. Thromb Res. 2016 Jan;137:119-125. doi: 10.1016/j.thromres.2015.10.014. Epub 2015 Oct 13. Thromb Res. 2016. PMID: 26614676 Clinical Trial.
Pharmacokinetics, efficacy, and safety of a plasma-derived VWF/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-VWD study).
Lissitchkov TJ, Buevich E, Kuliczkowski K, Stasyshyn O, Cerqueira MH, Klukowska A, Joch C, Seifert W. Lissitchkov TJ, et al. Among authors: seifert w. Blood Coagul Fibrinolysis. 2017 Mar;28(2):152-162. doi: 10.1097/MBC.0000000000000568. Blood Coagul Fibrinolysis. 2017. PMID: 27203734 Free PMC article.
Long-Term Safety and Efficacy of Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Previously Treated Pediatric Patients with Hemophilia B: Results from a Phase 3b Extension Study.
Kenet G, Chambost H, Male C, Halimeh S, Lambert T, Li Y, Seifert W, Santagostino E. Kenet G, et al. Among authors: seifert w. Thromb Haemost. 2020 Apr;120(4):599-606. doi: 10.1055/s-0040-1705116. Epub 2020 Mar 17. Thromb Haemost. 2020. PMID: 32185782 Free article. Clinical Trial.
Efficacy and safety of rIX-FP in surgery: An update from a phase 3b extension study.
Pan-Petesch B, Nagao A, Karim FA, Tosetto A, Roman MTA, Seifert W, Li Y, Négrier C. Pan-Petesch B, et al. Among authors: seifert w. Thromb Res. 2020 Sep;193:139-141. doi: 10.1016/j.thromres.2020.05.046. Epub 2020 May 28. Thromb Res. 2020. PMID: 32559570 Free article. Clinical Trial. No abstract available.
An Open-Label Extension Study to Assess the Long-Term Efficacy and Safety of a Plasma-Derived von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Patients with von Willebrand Disease (SWIFT-VWDext Study).
Lissitchkov T, Klukowska A, Buevich E, Maltceva I, Auerswald G, Stasyshyn O, Seifert W, Rogosch T. Lissitchkov T, et al. Among authors: seifert w. J Blood Med. 2020 Oct 9;11:345-356. doi: 10.2147/JBM.S268907. eCollection 2020. J Blood Med. 2020. PMID: 33117020 Free PMC article.
209 results